MedTrace Logo

Guidelines for Drug Therapy of Hypertension: Closing the Loop

NCT00012636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2015-04-07

No results posted yet for this study

Summary

Hypertension is a major risk factor for heart disease and stroke. Evidence-based guidelines support the use of specific drugs for patients with specific comorbidities to maximize the decrease in cardiovascular risk; yet, many physicians do not follow these guidelines in choosing drug therapy.

Conditions

Interventions

PROCEDURE

Computer generated statements about guideline concordance of drug therapy deliver to clinicians

Sponsors & Collaborators

Principal Investigators

  • Mary K. Goldstein, MD MS · VA Palo Alto Health Care System, Palo Alto, CA

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2000-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00012636 on ClinicalTrials.gov